Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Ovarian Neoplasms 16Peritoneal Neoplasms 14Colorectal Neoplasms 11Uterine Cervical Neoplasms 9Stomach Neoplasms 9Endometrial Neoplasms 8Neoplasm Metastasis 7Urinary Bladder Neoplasms 4Triple Negative Breast Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Lung Neoplasms 4Fallopian Tube Neoplasms 4Esophageal Neoplasms 4Colonic Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Rectal Neoplasms 3Mesothelioma 3HIV Infections 3Cholangiocarcinoma 3Carcinoma, Renal Cell 3Carcinoma, Ovarian Epithelial 3Acquired Immunodeficiency Syndrome 3Uterine Neoplasms 2Uterine Cervical Dysplasia 2Squamous Intraepithelial Lesions 2Pancreatic Neoplasms 2Neoplasms 2Melanoma 2Esophageal Squamous Cell Carcinoma 2Carcinoma, Hepatocellular 2

Interventions

sodium thiosulfate 1Oxaliplatin 1Mitomycin 1Fluorouracil 1Doxorubicin 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Necrosis × Fluorouracil × Gynecologic × Clear all
NCT04847063 2026-04-14

Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies

National Institutes of Health Clinical Center (CC)

Phase 1 Recruiting
60 enrolled
GastrointestinalGynecologic

Appendiceal Neoplasms, Gastrointestinal Neoplasms, Necrosis, Ovarian Neoplasms, Peritoneal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡